Qinglong Yang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Cancer-related gene regulation
- Gut microbiota and health
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 3
- Gut microbiota and health 2
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Ashuai Du (4 shared papers)Haoxian Tang (10 shared papers)Jingtao Huang (4 shared papers)Nan Luo (3 shared papers)Xuan Zhang (5 shared papers)Aroona Razzaq (1 shared paper)Yuzheng Zhou (1 shared paper)Zongpeng Chen (1 shared paper)
- Journals
- Scientific Reports (2 papers)BMC Public Health (2 papers)Human Vaccines & Immunotherapeutics (1 paper)International Immunopharmacology (1 paper)Frontiers in Nutrition (1 paper)
- Partner nations
- China
In The Last Decade
Qinglong Yang
16 papers receiving 260 citations
Qinglong Yang's Hit Papers
Peers
Comparison fields: 5 of 57
- Cancer Research 136
- Molecular Biology 200
- Public Health, Environmental and Occupational Health 31
- Physiology 27
- Immunology 17
Countries citing papers authored by Qinglong Yang
This map shows the geographic impact of Qinglong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglong Yang more than expected).
Fields of papers citing papers by Qinglong Yang
This network shows the impact of papers produced by Qinglong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglong Yang. The network helps show where Qinglong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qinglong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma Hit paper breakdown → | 2022 | 145 |
| 2 | 2024 | 42 | |
| 3 | 2023 | 26 | |
| 4 | 2021 | 10 | |
| 5 | 2025 | 7 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 4 | |
| 9 | 2025 | 3 | |
| 10 | Ferroptosis synergistically sensitizes wee1 inhibitors: a bibliometric study | 2022 | 3 |
| 11 | 2024 | 3 | |
| 12 | Immunological significance of prognostic markers for breast cancer based on alternative splicing. | 2022 | 2 |
| 13 | Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML. | 2023 | 2 |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Qinglong Yang
Qinglong Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 18 papers that have together received 260 indexed citations. Recurring topics across this work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), Diet and metabolism studies (3 papers), Ferroptosis and cancer prognosis (2 papers), Gut microbiota and health (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Cancer Research (136 citations), Molecular Biology (200 citations), Public Health, Environmental and Occupational Health (31 citations), Physiology (27 citations) and Immunology (17 citations). Qinglong Yang has collaborated with scholars based in China. Frequent co-authors include Ashuai Du, Haoxian Tang, Jingtao Huang, Nan Luo, Xuan Zhang, Aroona Razzaq, Yuzheng Zhou, Zongpeng Chen, Zanxian Xia and Sixu Liu. Their work appears in journals such as Scientific Reports, BMC Public Health, Human Vaccines & Immunotherapeutics, International Immunopharmacology and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.